About the Authors

Takuto Nakamura

Contributed equally to this work with: Takuto Nakamura, Satoko Sekimoto

Roles Formal analysis, Resources, Software, Writing – original draft, Writing – review & editing

Affiliations Department of Informatics, The University of Electro-communications, Tokyo, Japan, Japan Society for the Promotion of Science, Tokyo, Japan

Satoko Sekimoto

Contributed equally to this work with: Takuto Nakamura, Satoko Sekimoto

Roles Data curation, Formal analysis, Writing – original draft, Writing – review & editing

Affiliation Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan

Genko Oyama

Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing

Affiliation Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan

Yasushi Shimo

Roles Funding acquisition, Writing – review & editing

Affiliation Department of Informatics, The University of Electro-communications, Tokyo, Japan

Nobutaka Hattori

Roles Funding acquisition, Writing – review & editing

nhattori@juntendo.ac.jp

Affiliation Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan

Hiroyuki Kajimoto

Roles Conceptualization, Investigation, Resources, Software, Writing – review & editing

Affiliation Department of Informatics, The University of Electro-communications, Tokyo, Japan

Competing Interests

NH has received speaker honoraria from Dai-Nippon Sumitomo, Otsuka, Takeda, Kyowa Hakko-Kirin, GSK, Nippon Boehringer Ingelheim, FP, Eisai, Kissei, Nihon Medi-physics, Novartis, Biogen Idec Japan, AbbVie, Astellas, Boston Scientific Japan, Sanofi, Pfizer Japan, Alexion, Mylan N.V, MSD, Daiichi Sankyo, and MDS. NH has received consultancies and subcontracting from Dai-Nippon Sumitomo, Biogen Idec, Otsuka, Takeda, Kyowa Hakko-Kirin, Meiji Seika, Hisamitsu, Kao. GO has received speaker honoraria from Medtronic, Boston Scientific, Otsuka Pharmaceutical, Sumitomo Dainippon Pharma, Novartis Pharma, MSD, Nihon Medi-Physics, FP Pharmaceutical Corporation, and Kyowa Hakko Kirin, and Abbvie. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.